Splicing Factor SF3B4 Suppresses Pancreatic Cancer Growth and Migration by Inhibiting Autophagy

So-Hyun Choi1,2,3, Jiyoon Seo1,2,3, Seung Min Jeong4,2,3

  • 1Department of Biochemistry, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

Anticancer Research
|January 30, 2026
PubMed
Abstract

Insights

SF3B4 acts as a tumor suppressor in pancreatic cancer by inhibiting autophagy and increasing reactive oxygen species (ROS). This finding offers a new strategy to combat pancreatic ductal adenocarcinoma (PDAC) and chemoresistance.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Metabolism

Background:

  • Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal cancer with known chemoresistance and metabolic adaptations like increased autophagy.
  • The splicing factor SF3B4's role in PDAC is not well understood, despite its oncogenic function in other cancers.

Purpose of the Study:

  • To investigate the functional and mechanistic role of SF3B4 in pancreatic ductal adenocarcinoma (PDAC).

Main Methods:

  • SF3B4 expression analysis in PDAC patient datasets and experimental models.
  • Functional assays assessing cell proliferation, colony formation, migration, and autophagy in PDAC cells.
  • Evaluation of reactive oxygen species (ROS) levels, 5-fluorouracil (5-FU) sensitivity, and apoptotic responses.

Main Results:

  • SF3B4 functions as a tumor suppressor in PDAC by inhibiting autophagy, a critical survival pathway for this cancer.
  • SF3B4 overexpression reduced PDAC cell proliferation, colony formation, and migration.
  • SF3B4 suppressed autophagic flux, leading to increased ROS, which inhibited tumor phenotypes. This effect was reversed by N-acetylcysteine (NAC).
  • SF3B4 overexpression enhanced PDAC cell sensitivity to 5-FU and increased apoptosis.

Conclusions:

  • SF3B4 acts as a context-dependent tumor suppressor in PDAC by modulating autophagy and redox homeostasis.
  • The SF3B4-autophagy-ROS pathway presents a potential therapeutic target for suppressing PDAC progression and overcoming chemoresistance.

Related Concept Videos

RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
60.6K
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
25.2K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.3K
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
3.9K
Factors Influencing Microbial Growth: pH01:29

Factors Influencing Microbial Growth: pH

Microorganisms are classified as acidophiles, neutrophiles, or alkaliphiles based on their pH growth preferences, reflecting their adaptations to specific environments. Maintaining a stable intracellular pH is critical for macromolecular stability and enzymatic activity, which can be challenged by external pH variations.Neutrophiles, such as Escherichia coli, grow optimally between pH 5.5 and 8.0. These microorganisms inhabit neutral or slightly acidic environments and employ mechanisms like...
1.2K
Factors Influencing Microbial Growth: Temperature01:27

Factors Influencing Microbial Growth: Temperature

Microorganisms display remarkable adaptations, enabling them to thrive in diverse ecological niches across a wide range of temperatures. Temperature profoundly influences microbial growth by affecting enzymatic activity, membrane fluidity, and other cellular processes.Each microorganism operates within a specific temperature range defined by three cardinal points: minimum, optimum, and maximum. Below the minimum temperature, membranes lose fluidity, halting transport processes. Above the...
1.2K